Follow us on:
Breaking News
March 13, 2026
CP Direct: Friday Edition
Breaking News
FederalEquipment_ENL_0326_650x90

Lilly to Invest $3B to Expand GLP-1 Manufacturing Capacity in China 

 
Lilly expands manufacturing in India

Investment will involve Lilly’s Suzhou facility as well as developing a network of partners to help expand production.
Read More >>

Top Headlines

Breaking News
Promotions & Moves

Grail Inc. Announces CEO Transition

Josh Ofman to serve as CEO following Bob Ragusa’s retirement in June.

SPONSOR

Water for Injection: Strategic Utility and the Case for Outsourcing

Water for injection (WFI) sits at the heart of injectable drug manufacturing.

Breaking News
Promotions & Moves

Fujifilm Biotechnologies Appoints Chief Business Officer

Christiane Bardroff brings 18+ years of experience and leadership across customer stewardship and biopharmaceutical operations.

Breaking News

Almirall Opens New Offices in China to Advance Medical Dermatology Innovation

This combines the company’s strong in-house R&D capabilities with collaborations in the country.

SPONSOR

Five Decades of Partnership in Solid Oral Dose Manufacturing

How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, and quality expectations.

Samsung_Webinar_04-15-26_650x250

Breaking News

Lyocontract Breaks Ground on €50M Facility in Germany

Lyocontract was joined by its partner Syntegon, which will equip the new facility with a complete line for filling and lyophilization.

Features

The 2026 Biologics Wave: Which Innovations Will Break Through?

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

SPONSOR

[VIDEO] What Should Biotechs Look for in a CDMO?

Contract Pharma sits down with Rod Ketner, VP of Business Operations at Serán Bioscience, for his thoughts.

Featured Resources

Free Basic Listing SPOTLIGHT

Oximio

Established in 2004, Oximio is a leading provider of global supply chain solutions bringing experience and expertise to the clinical research industry. With UK headquarters, we have owned and partner depots and customs bonded warehouses in Europe, MENA, Africa, North America, LATAM and APAC. Oximio has a large and loyal clientele working with global pharmaceutical companies, global CROs and leading CMOs.

 

Solution Center SPOTLIGHT

LOTTE BIOLOGICS

LOTTE Biologics is a contract development & manufacturing organization delivering integrated biologics & bioconjugate services across the full product lifecycle. Our capabilities encompass phase-appropriate DS manufacturing for mammalian-cell-based biologics, including mAbs, fusion proteins, multispecifics, & integrated ADC manufacturing.